Next Up for PCPs: Managing CKM Next Up for PCPs: Managing CKM
An AHA presidential advisory introduced the concept of cardiovascular-kidney-metabolic health, with PCPs as key providers.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - December 5, 2023 Category: Internal Medicine Tags: Family Medicine/Primary Care Source Type: news

Semaglutide Reduces Cardio Risk in Obesity Without Diabetes Semaglutide Reduces Cardio Risk in Obesity Without Diabetes
Anne Peters discusses recent data on semaglutide and cardiovascular outcomes in patients with preexisting cardiovascular disease and obesity, but with no history of diabetes.Medscape Diabetes & Endocrinology (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 5, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology Commentary Source Type: news

Cost Hurdles Can Keep Patients From Accessing GLP-1 Receptor Agonists
(MedPage Today) -- ANAHEIM, Calif. -- Insurance coverage and out-of-pocket costs for GLP-1 receptor agonists pose serious barriers to patients prescribed these drugs for type 2 diabetes and other indications, two single-site studies showed.... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - December 5, 2023 Category: Cardiology Source Type: news

Rocket Pharma Seeks Gene Therapy Revolution For Genetic Heart Disease
Rocket Pharma has a pipeline of six gene therapy programs addressing cardiovascular and hematology-based diseases at the genetic level. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 5, 2023 Category: Pharmaceuticals Authors: Yola Robert, Senior Contributor Tags: ForbesWomen /forbeswomen Leadership /leadership Innovation /innovation Healthcare /healthcare standard Source Type: news

Gaps Persist in Actual Versus Optimal Atherosclerotic Cardiovascular Disease Care
TUESDAY, Dec. 5, 2023 -- Roughly half of patients with atherosclerotic cardiovascular disease (ASCVD) adopt optimal prevention strategies across racial and ethnic subgroups, according to a study published online Dec. 1 in JAMA Network... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 5, 2023 Category: Pharmaceuticals Source Type: news

Win for Vegan Diet; Injectable Balloon Catheters OK'd; OAC Options After Failed DOAC
(MedPage Today) -- Do people with a family history of cardiovascular disease have a particular need to consume more eicosapentaenoic/docosahexaenoic acids? (Circulation) A healthy vegan diet held a cardiometabolic advantage over omnivorous eating... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - December 5, 2023 Category: Cardiology Source Type: news

NCDs Are Killing the Caribbean – PODCAST
By Marty LoganKATHMANDU, Dec 5 2023 (IPS) If I asked you to name the world’s most deadly diseases I’m guessing that you might say HIV/AIDS, tuberculosis, cholera, maybe even COVID-19. In fact, those have all been major killers throughout human history – and some like TB continue to be so, especially in low-income countries. But there is one group of diseases that is responsible for the deaths of more than two-thirds of people on earth. Let that sink in for moment. For every three people who die, two are killed by these illnesses, which are known as non-communicable diseases, or NCDs. You probably know about many of...
Source: IPS Inter Press Service - Health - December 5, 2023 Category: International Medicine & Public Health Authors: Marty Logan Tags: Headlines Health Latin America & the Caribbean Multimedia Podcast TerraViva United Nations Non-communicable Diseases (NCDs) Source Type: news

Wildfire, evacuation, and cardiovascular events: a spatial exposure approach - Arabadjis SD, Sweeney SH, Kenner CE, Tedesco DJ.
Increasingly, adverse health effects from wildfire exposure are not limited to select populations in the wildland-urban interface. As wildfires continue to grow in frequency and intensity, they are also continuing to encroach on urban areas, putting larger... (Source: SafetyLit)
Source: SafetyLit - December 5, 2023 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

Pharmacists Can Spur Switch to Recommended Drugs for Diabetes Patients With CVD
(MedPage Today) -- ANAHEIM, Calif. -- A pharmacist-led intervention using notes in the electronic health record (EHR) proved effective for convincing primary care providers to switch veterans with diabetes and cardiovascular disease (CVD) to... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - December 5, 2023 Category: Cardiology Source Type: news

Statin Use Remains Low for At-Risk Patients Statin Use Remains Low for At-Risk Patients
Expanded prescribing guidelines have not boosted statin use among patients who are at risk for atherosclerotic cardiovascular disease.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 4, 2023 Category: Cardiology Tags: Family Medicine/Primary Care News Source Type: news

CVD Mortality Similar With Diuretic, ACE Inhibitor, or Calcium Channel Blocker
MONDAY, Dec. 4, 2023 -- For patients with hypertension and at least one other coronary heart disease risk factor, cardiovascular disease (CVD) mortality is similar for those receiving a thiazide-type diuretic, calcium channel blocker (CCB), or... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 4, 2023 Category: Pharmaceuticals Source Type: news

High Blood Pressure in Babies Linked to Adult Atherosclerosis
(MedPage Today) -- The link between childhood blood pressure (BP) and adult atherosclerosis appeared stable going all the way back to infancy, suggesting that efforts to prevent arterial thickening may be beneficial starting at the earliest life... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - December 4, 2023 Category: Cardiology Source Type: news

Claire Fair Joins Cardiovascular Logistics as the Company's Chief People Officer
Cardiovascular Logistics, the most comprehensive cardiovascular platform in the country, announced that Claire Fair is the company's new Chief People Officer responsible for its human resources strategy and operations. Fair brings advanced knowledge across all HR disciplines to... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 4, 2023 Category: Pharmaceuticals Tags: PER Source Type: news

Roche enters into a definitive merger agreement to acquire Carmot Therapeutics, including three clinical stage assets with best-in-class potential in obesity and diabetes
Carmot Therapeutics ’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases both as standalone medicines and in combination with Roche ’s in-house assetsLead asset CT-388 is a Phase-2 ready dual GLP-1/GIP agonist with best-in-class potential for the treatment of obesity and its comorbiditiesUnder the terms of the agreement, Roche will pay a purchase price of USD 2.7 billion upfront and additional milestone payments of up to USD 400 millionBasel, 4 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the entry into a definitive merger a...
Source: Roche Investor Update - December 4, 2023 Category: Pharmaceuticals Source Type: news

Roche enters into a definitive merger agreement to acquire Carmot Therapeutics, including three clinical stage assets with best-in-class potential in obesity and diabetes
Carmot Therapeutics ’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases both as standalone medicines and in combination with Roche ’s in-house assetsLead asset CT-388 is a Phase-2 ready dual GLP-1/GIP agonist with best-in-class potential for the treatment of obesity and its comorbiditiesUnder the terms of the agreement, Roche will pay a purchase price of USD 2.7 billion upfront and additional milestone payments of up to USD 400 millionBasel, 4 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the entry into a definitive merger a...
Source: Roche Media News - December 4, 2023 Category: Pharmaceuticals Source Type: news